| 名稱 | FGFR2-BICC1/BaF3 |
| 型號(hào) | CBP73268 |
| 報(bào)價(jià) | ![]() |
| 特點(diǎn) | FGFR2-BICC1/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 【新品發(fā)布】MRD標(biāo)準(zhǔn)品_40+位點(diǎn)panel標(biāo)準(zhǔn)品
- 降糖&減肥明星靶點(diǎn):GLP1R/GIPR/GCGR
- MicroRNA或可特異性地殺死攜帶常見突變的癌細(xì)胞
- PVRIG CD112藥靶篩選模型
- IL-21藥篩細(xì)胞模型
- THR-β激動(dòng)劑:NASH治療的新希望?
- 人類白細(xì)胞抗原HLA基因分型標(biāo)準(zhǔn)品
- Science:腫瘤非整倍體與癌癥免疫療法反應(yīng)下降相關(guān)聯(lián)
- 老靶點(diǎn)迭代突破創(chuàng)新:Her2靶點(diǎn)細(xì)胞模型
- 【盤點(diǎn)】癌癥免疫檢查點(diǎn)療法的現(xiàn)狀與展望
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73268FGFR2-BICC1/BaF3
- 詳細(xì)內(nèi)容
CBP73268 | |
| I. Introduction | |
Cell Line Name: | FGFR2-BICC1/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
| Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
FGFR2-BICC1 results from the fusion of FGFR2 and BICC1, resulting in the ability to induce oligomerization, Fgfr kinase activity, Mapk signaling and transformation of cells in culture and in animal models (PMID: 23558953, PMID: 24122810, PMID: 28416604). FGFR2-BICC1 has been identified in intrahepatic cholangiocarcinoma (PMID: 25608663, PMID: 31899106). | |
| III. Representative Data | |
1.WB of FGFR2-BICC1/BaF3
| |
2.Sanger of FGFR2-BICC1/BaF3
| |
3. Anti-proliferation assay | |
| |
Figure 3. CTG Proliferation Assay of BaF3 FGFR2-BICC1 Cells (C8). | |







會(huì)員_a.png)